Legal & General Group
INBX icon

Legal & General Group’s Inhibrx INBX Stock Holding History

Legal & General Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$487K Buy
5,138
+129
+3% +$12.9K ﹤0.01% 2407
2026
Q1 		$337K Buy
5,009
+4,215
+531% +$313K ﹤0.01% 2452
2025
Q4 		$62.7K Buy
794
+26
+3% +$1.77K ﹤0.01% 2688
2025
Q3 		$25.9K Hold
768
– – ﹤0.01% 2937
2025
Q2 		$11K Sell
768
-277
-27% -$3.58K ﹤0.01% 3260
2025
Q1 		$14.6K Hold
1,045
– – ﹤0.01% 3055
2024
Q4 		$16.1K Hold
1,045
– – ﹤0.01% 3106
2024
Q3 		$16.4K Sell
1,045
-3,026
-74% -$42.5K ﹤0.01% 3129
2024
Q2 		$57.5K Buy
+4,071
New +$63.6K ﹤0.01% 2778

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Legal & General Group's INBX Position: Q2 2026 in Review

Legal & General Group increased its Inhibrx (INBX) stake by 2.6% in Q2 2026, buying an estimated $12.9K and bringing the position to 5,138 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #2407.

Legal & General Group first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Legal & General Group held 5,138 shares of Inhibrx worth $487K as of Q2 2026.
  • Legal & General Group bought 129 Inhibrx shares in Q2 2026, an estimated $12.9K.
  • Inhibrx made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2407 holding.
  • Legal & General Group first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.